Efficacy and safety of intermittent intravenous doxercalciferol in the treatment of secondary hyperparathyroidism in Chinese patients on maintenance hemodialysis: a phase II, open-label, prospective, multicenter study - Yang, Guang; Huang, Yaoyu; Ge, Yifei; Yu, Xiangbao; Liu, Li; Xiang, Li; Liu, Bin; Gao, Chaoqing; Liu, Changhua; Xu, Yong; Li, Wenwen; Lou, Donghua; et al. (Frontiers in Pharmacology, 2025)